TY - CHAP U1 - Konferenzveröffentlichung A1 - Ismer, Bruno T1 - History and Perspective of Radiofrequency Catheter Ablation T2 - Biomedical Engineering / Biomedizinische Technik N2 - Since direct current high energy shock fulguration was initially performed in the mid 1980s, ablation of cardiac arrhythmias has come to widespread use. Today the most frequently used energy source for catheter ablation is radio frequency (RF). It was the German engineer Peter Osypka who made available the HAT 100 as the first simple commercial RF ablator. Nevertheless, in the first years of ablation, physicians were effectively working in the dark. Until today with an increasing understanding of arrhythmia mechanisms, both at the atrial and ventricular levels, this curative technology has made tremendous progress. Now, due to crucial improvement of RF ablation generators, temperature and contact force sensor catheters in combination with non-flouroscopic electroanatomical mapping technologies, computerized temperature and impedance controlled radiofrequency catheter ablation can be used to cure all types of arrhythmias including atrial and ventricular fibrillation. For the latter, cooled ablation by saline solution irrigated catheters has been developed to a widely used standard method. This procedure resulting in pulmonary vein isolation requires transseptal puncture and is technically demanding. Nevertheless, it has shown to be more effective than antiarrhythmic drug therapy. While earliest RF ablations were performed with non-steerable catheters, today are used steerable sensor catheters without or with external and internal cooling and tips of 4mm or 8mm length. Further innovations like integration of mapping and cardiac imaging give exact information of the number of pulmonary veins and branching patterns and help to correlate electrical signals with anatomical structures. The magnetic navigation significantly improved the success rates and safety of catheter ablation. Thus, in most cases RF catheter ablation has developed in the treatment of supraventricular arrhythmias from an alternative approach to drug therapy into the first therapeutic choice providing low complication rates. In future, robotic navigation will further simplify procedures and reduce radiation exposure of this curative approach. Y1 - 2014 SN - 0013-5585 (Print) SS - 0013-5585 (Print) SN - 1862-278X (Online) SS - 1862-278X (Online) U6 - https://doi.org/10.1515/bmt-2014-5015 DO - https://doi.org/10.1515/bmt-2014-5015 VL - 59 IS - S1 SP - S1203 S1 - 1 PB - Walter de Gruyter CY - Berlin, Boston ER -